Fungal calcium channels as therapeutic targets for AIDS-associated opportunistic

真菌钙通道作为艾滋病相关机会性感染的治疗靶点

• 批准号: 7683423
• 负责人: ANGIE GELLI
• 金额: $ 36.6万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-02-01 至 2012-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7683423
• 关键词: Acquired Immunodeficiency Syndrome; Address; Adjuvant; Anabolism; Antifungal Agents; Arts; Attenuated; Biological; Biological Assay; Calcium Channel; Candida albicans; Cell Line; Cells; Complex; Coupled; Cryptococcal Meningitis; Cryptococcus neoformans; Cryptococcus neoformans infection; Development; Doctor of Philosophy; Drug Combinations; Drug Compounding; Economics; Endoplasmic Reticulum; Environment; Equilibrium; Ergosterol; Event; Fluorescence Resonance Energy Transfer; Fungal Meningitis; Growth; Image; Immune response; Immunosuppression; In Vitro; Industrial fungicide; Lead; Life; Maintenance Therapy; Mammalian Cell; Mediating; Meningoencephalitis; Modeling; Molecular; Mus; Mycoses; NIH Program Announcements; Opportunistic Infections; Patch-Clamp Techniques; Patients; Pharmaceutical Preparations; Physiological Processes; Physiology; Play; Preclinical Drug Evaluation; Role; Screening procedure; Signal Transduction; Structure of thyroid parafollicular cell; T-Lymphocyte; Testing; Tissues; Triazoles; Virulence; assay development; base; channel blockers; drug development; endoplasmic reticulum stress; high throughput screening; immune function; in vivo; inhibitor/antagonist; mortality; mutant; novel; novel strategies; patch clamp; pathogen; prevent; public health relevance; small molecule; small molecule libraries; synergism; therapeutic target; tool

DESCRIPTION (provided by applicant): We have developed a simple and reliable assay to identify small molecule inhibitors of the Cch1-Mid1 Ca2+ channel. This complex promotes many critical aspects of fungal physiology. In Cryptococcus neoformans, Candida albicans and C. glabrata, Cch1-Mid1 signaling plays a crucial role in tolerating and surviving ER stress conditions that are induced by inhibitors of ergosterol biosynthesis, such as triazole antifungal drugs. C. neoformans is the leading cause of fungal meningitis in AIDS patients and other patients without adequate T-cell-dependent immune functions. Small molecule modulators would provide critical tools for studying Ca2+- mediated signaling events during ER stress and might even lead the way to the development of important adjuvants that might synergize with existing antifungals and enhance the treatment of life-threatening fungal infections. However, there are currently no inhibitors of Cch1 signaling. Our assay takes advantage of the model fungal pathogen C. neoformans, which requires the Cch1-Mid1 Ca2+ channel for its survival in low Ca2+ environments. On low Ca2+ media in the presence of small molecules that block Cch1 activity and prevent Cch1-mediated signaling, the growth of C. neoformans would be arrested. Thus the assay uses a simple readout (growth versus growth arrest) to identify small molecules that inhibit the Cch1-Mid1 channel. Because the assay is reproducible and has a simple readout, this assay is highly amenable to high-throughput screening. We will use a counter screen to prioritize the lead compounds and also validate the biological relevance of each molecule through patch clamp techniques and FRET- based Ca2+ imaging. We anticipate that a screen using this assay may provide a crucial step forward in understanding the role of the Cch1-Mid1 channel in critical Ca2+-mediated signaling events and in developing a novel strategy for treating fungal infections. This project is responsive to the program announcement for the development of assays for high-throughput drug screening. PUBLIC HEALTH RELEVANCE: This study aims to understand the role of a calcium channel that governs essential physiological processes in fungal pathogens as a means to assess its viability as a target for antifungal drug development. Because fungal infections are life threatening for patients with a suppressed immune response, the development of more efficacious and better-tolerated drugs is essential.

描述（由申请人提供）：我们已经开发了一种简单可靠的检测方法来鉴定Cch1-Mid1 Ca2+通道的小分子抑制剂。这个复合体促进了真菌生理学的许多关键方面。在新型隐球菌、白色念珠菌和光秃隐球菌中，Cch1-Mid1信号在耐受和存活麦角甾醇生物合成抑制剂（如三唑类抗真菌药物）诱导的内质网应激条件中起着至关重要的作用。在艾滋病患者和其他缺乏t细胞依赖免疫功能的患者中，新形梭菌是引起真菌性脑膜炎的主要原因。小分子调节剂将为研究内质网应激期间Ca2+介导的信号事件提供关键工具，甚至可能引领重要佐剂的发展，这些佐剂可能与现有的抗真菌药物协同作用，增强对危及生命的真菌感染的治疗。然而，目前还没有Cch1信号的抑制剂。我们的实验利用了模型真菌病原体C. neoformans，它需要Cch1-Mid1 Ca2+通道才能在低Ca2+环境中存活。在低Ca2+介质中，存在阻断Cch1活性和阻止Cch1介导的信号传导的小分子，新生C.的生长将被阻止。因此，该分析使用简单的读数（生长与生长停止）来识别抑制Cch1-Mid1通道的小分子。因为该分析是可重复的，有一个简单的读数，该分析是高度适用于高通量筛选。我们将使用计数器筛选优先考虑先导化合物，并通过膜片钳技术和基于FRET的Ca2+成像验证每个分子的生物学相关性。我们预计，使用这种方法的筛选可能为理解Cch1-Mid1通道在关键Ca2+介导的信号事件中的作用以及开发治疗真菌感染的新策略提供关键的一步。本项目是响应高通量药物筛选试验开发项目公告。公共卫生相关性：本研究旨在了解控制真菌病原体基本生理过程的钙通道的作用，作为评估其作为抗真菌药物开发靶点的可行性的一种手段。由于真菌感染对免疫反应受到抑制的患者来说是危及生命的，因此开发更有效、耐受性更好的药物至关重要。